MetaADEDB 2.0 @ LMMD
Sulfasalazine
(NCEXYHBECQHGNR-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)ccc1O
Type(s)
Approved
ATC code(s)
A07EC01; G01AE10
Molecular Formula:
C18H14N4O5S
Molecular Weight:
398.393
Log P:
4.8554
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
3
TPSA:
149.69
CAS Number(s):
599-79-1; 737754-28-8
Synonym(s)
1.
Sulfasalazine
2.
Salicylazosulfapyridine
3.
Asulfidine
4.
Azulfadine
5.
Azulfidine
6.
Azulfidine EN
7.
Colo-Pleon
8.
Pleon
9.
Pyralin EN
10.
Salazopyrin
11.
Salazosulfapyridine
12.
Sulfasalazin medac
13.
Sulfasalazin-Heyl
14.
Sulfasalazine FNA
15.
Sulphasalazine
16.
Ucine
17.
Ulcol
18.
ratio-Sulfasalazine
19.
Colo Pleon
20.
Sulfasalazin Heyl
21.
ratio Sulfasalazine
External Link(s)
MeSHD012460
PubChem Compound5339
BindingDB50097125
50293265
50103596
ChEBI94500
9334
CHEMBLCHEMBL1206016
CHEMBL100848
CHEMBL421
DrugBankDB00795
DrugCentral2525
IUPHAR/BPS Guide to PHARMACOLOGY4840
KEGGcpd:C07316
dr:D00448
Therapeutic Target DatabaseD02ZTJ
D0GH2C
ZINC85550135
3831490
14768602
100030102
100031653
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 397
Canada Vigilance: 312
Canada Vigilance
US FAERS
2NauseaFAERS: 135
Canada Vigilance: 23
4146729
6151882
19217336
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
3HeadacheFAERS: 75
Canada Vigilance: 19
4146729
19217336
CTD
SIDER
Canada Vigilance
US FAERS
4MalaiseFAERS: 66
Canada Vigilance: 8
Canada Vigilance
US FAERS
5Abdominal discomfortFAERS: 62
Canada Vigilance: 14
Canada Vigilance
US FAERS
6VomitingFAERS: 55
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
7FatigueFAERS: 53
Canada Vigilance: 9
Canada Vigilance
US FAERS
8HypersensitivityFAERS: 52
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
9ArthralgiaFAERS: 41
Canada Vigilance: 2
4384520CTD
SIDER
Canada Vigilance
US FAERS
10LymphadenopathyFAERS: 39
Canada Vigilance: 5
Canada Vigilance
US FAERS
11Drug effect incompleteFAERS: 38US FAERS
12Drug exposure during pregnancyFAERS: 36US FAERS
13NeutropeniaFAERS: 33
Canada Vigilance: 5
2571387CTD
SIDER
Canada Vigilance
US FAERS
14PruritusFAERS: 33
Canada Vigilance: 7
6146502CTD
SIDER
Canada Vigilance
US FAERS
15UrticariaFAERS: 33
Canada Vigilance: 5
2859799
2880997
CTD
SIDER
Canada Vigilance
US FAERS
16AgranulocytosisFAERS: 32
Canada Vigilance: 2
2880997
4146729
6127975
CTD
SIDER
Canada Vigilance
US FAERS
17Stevens-Johnson SyndromeFAERS: 31
Canada Vigilance: 3
25811541CTD
SIDER
Canada Vigilance
US FAERS
18DizzinessFAERS: 29
Canada Vigilance: 2
4146729CTD
SIDER
Canada Vigilance
US FAERS
19PneumoniaFAERS: 29
Canada Vigilance: 1
2859799
2894766
CTD
SIDER
Canada Vigilance
US FAERS
20PancytopeniaFAERS: 28SIDER
US FAERS
21AstheniaFAERS: 27US FAERS
22Abdominal PainFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
23EosinophiliaFAERS: 24
Canada Vigilance: 2

View details

CTD
SIDER
Canada Vigilance
US FAERS
24ErythemaFAERS: 24
Canada Vigilance: 3

View details

CTD
SIDER
Canada Vigilance
US FAERS
25Weight decreasedFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
26LeukopeniaFAERS: 23
Canada Vigilance: 5
4146729
12795783
CTD
SIDER
Canada Vigilance
US FAERS
27PainFAERS: 22
Canada Vigilance: 3
Canada Vigilance
US FAERS
28ChillsFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
29White blood cell count decreasedFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
30treatment failureFAERS: 19
Canada Vigilance: 25
Canada Vigilance
US FAERS
31Cerebral InfarctionFAERS: 18US FAERS
32HepatitisFAERS: 18
Canada Vigilance: 1

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
33Toxic Epidermal NecrolysisFAERS: 18SIDER
US FAERS
34Alanine Aminotransferase IncreasedFAERS: 17OFFSIDES
US FAERS
35Rheumatoid ArthritisFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
36Feeling abnormalFAERS: 15US FAERS
37Musculoskeletal stiffnessFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
38SwellingFAERS: 15US FAERS
39ThrombocytopeniaFAERS: 15
Canada Vigilance: 2
2572687
9776124
CTD
SIDER
Canada Vigilance
US FAERS
40Oropharyngeal painFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
41AlopeciaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
42ChromaturiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
43Histiocytosis haematophagicFAERS: 13OFFSIDES
US FAERS
44Joint swellingFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
45SepsisFAERS: 1311672959CTD
US FAERS
46TachycardiaFAERS: 13US FAERS
47Transaminases increasedFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
48ColitisFAERS: 12

View details

CTD
US FAERS
49DyspepsiaFAERS: 12
Canada Vigilance: 1
6151882CTD
SIDER
Canada Vigilance
US FAERS
50Peripheral swellingFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
51Anti-neutrophil cytoplasmic antibody positive vasculitisFAERS: 11US FAERS
52Drug ineffective for unapproved indicationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
53DysgeusiaFAERS: 11US FAERS
54Infectious MononucleosisFAERS: 11US FAERS
55MyalgiaFAERS: 11
Canada Vigilance: 4
Canada Vigilance
US FAERS
56StomatitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
57jaundiceFAERS: 11
Canada Vigilance: 2
10394456CTD
SIDER
Canada Vigilance
US FAERS
58ArthropathyFAERS: 10US FAERS
59Disseminated Intravascular CoagulationFAERS: 108104747CTD
OFFSIDES
US FAERS
60InfectionFAERS: 10SIDER
US FAERS
61Lip swellingFAERS: 10US FAERS
62Product use issueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
63Respiratory FailureFAERS: 10OFFSIDES
US FAERS
64AnxietyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Aspartate Aminotransferase IncreasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
66Blood creatine phosphokinase increasedFAERS: 9US FAERS
67Eosinophilic PneumoniaFAERS: 9US FAERS
68Erythema MultiformeFAERS: 9SIDER
US FAERS
69GlomerulonephritisFAERS: 9US FAERS
70InflammationFAERS: 9
Canada Vigilance: 1
17259377
22427801
CTD
Canada Vigilance
US FAERS
71Night sweatsFAERS: 9US FAERS
72PalpitationsFAERS: 9US FAERS
73Pharyngolaryngeal PainFAERS: 9US FAERS
74PolyneuropathyFAERS: 9OFFSIDES
US FAERS
75Product use in unapproved indicationFAERS: 9US FAERS
76AsthmaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
77Febrile NeutropeniaFAERS: 8US FAERS
78LeukocytosisFAERS: 813680174CTD
US FAERS
79Pulmonary FibrosisFAERS: 816512452CTD
US FAERS
80SynovitisFAERS: 82880997CTD
US FAERS
81AngioedemaFAERS: 72859799CTD
SIDER
US FAERS
82Chest PainFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
83DehydrationFAERS: 7US FAERS
84Diabetes MellitusFAERS: 7US FAERS
85Eosinophilic myocarditisFAERS: 7SIDER
US FAERS
86Myocardial InfarctionFAERS: 7US FAERS
87Product quality issueFAERS: 7US FAERS
88Product substitution issueFAERS: 7US FAERS
89PurpuraFAERS: 7
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
90Rash erythematousFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
91TinnitusFAERS: 7SIDER
US FAERS
92AgeusiaFAERS: 6OFFSIDES
US FAERS
93ArthritisFAERS: 6
Canada Vigilance: 2
2571387
8298382
19217336
CTD
Canada Vigilance
US FAERS
94Back PainFAERS: 6US FAERS
95DermatitisFAERS: 68105680
11672959
17032600
CTD
SIDER
US FAERS
96EczemaFAERS: 6OFFSIDES
US FAERS
97HypotensionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Impaired work abilityFAERS: 6US FAERS
99LymphocytosisFAERS: 6
Canada Vigilance: 1
1362531CTD
OFFSIDES
Canada Vigilance
US FAERS
100Maternal exposure during pregnancyFAERS: 6US FAERS
101Mononucleosis syndromeFAERS: 6US FAERS
102Neck PainFAERS: 6US FAERS
103Oculomucocutaneous syndromeFAERS: 6US FAERS
104Pericardial effusionFAERS: 6US FAERS
105Pharmaceutical product complaintFAERS: 6US FAERS
106SplenomegalyFAERS: 6
Canada Vigilance: 1
18084702
26165751
CTD
Canada Vigilance
US FAERS
107Toxicity to various agentsFAERS: 6US FAERS
108Urinary tract infectionFAERS: 6SIDER
US FAERS
109nervous system disorderFAERS: 6SIDER
US FAERS
110Altered state of consciousnessFAERS: 5US FAERS
111CataractFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Cerebrovascular accidentFAERS: 5US FAERS
113Chest discomfortFAERS: 5US FAERS
114ChokingFAERS: 5US FAERS
115Contraindicated product administeredFAERS: 5US FAERS
116Cytolytic hepatitisFAERS: 5OFFSIDES
US FAERS
117DementiaFAERS: 5US FAERS
118Drug DependenceFAERS: 5US FAERS
119Exfoliative rashFAERS: 5US FAERS
120Eye painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
121HepatosplenomegalyFAERS: 5US FAERS
122HepatotoxicityFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
123Joint Range of Motion DecreasedFAERS: 5US FAERS
124LethargyFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
125MyocarditisFAERS: 511672959CTD
SIDER
US FAERS
126PancreatitisFAERS: 5
Canada Vigilance: 3
12235076CTD
SIDER
Canada Vigilance
US FAERS
127PetechiaeFAERS: 5SIDER
US FAERS
128PharyngitisFAERS: 5
Canada Vigilance: 2
10394456CTD
Canada Vigilance
US FAERS
129RhabdomyolysisFAERS: 5SIDER
US FAERS
130Skin lesionFAERS: 5US FAERS
131TuberculosisFAERS: 5US FAERS
132Urinary RetentionFAERS: 5US FAERS
133Wrong technique in drug usage processFAERS: 5US FAERS
134Acute kidney injuryFAERS: 4US FAERS
135AnosmiaFAERS: 4OFFSIDES
US FAERS
136Atrial FibrillationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
137BlindnessFAERS: 4US FAERS
138Blood alkaline phosphatase increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
139Blood lactate dehydrogenase increasedFAERS: 4
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
140Cardiac ArrestFAERS: 4US FAERS
141CytopeniaFAERS: 4US FAERS
142Deep Vein ThrombosisFAERS: 4US FAERS
143Depressed moodFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
144Disease recurrenceFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
145Drug level increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
146DysarthriaFAERS: 4US FAERS
147Erythema NodosumFAERS: 4US FAERS
148False negative investigation resultFAERS: 4US FAERS
149FlatulenceFAERS: 4US FAERS
150FlushingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Gastric ulcerFAERS: 4US FAERS
152General physical condition abnormalFAERS: 4US FAERS
153Heparin-induced thrombocytopeniaFAERS: 4US FAERS
154HepatomegalyFAERS: 412587019
18084702
CTD
US FAERS
155Human herpes virus 6 serologyFAERS: 4US FAERS
156Human herpes virus 6 serology positiveFAERS: 4OFFSIDES
US FAERS
157HypoxiaFAERS: 4US FAERS
158Lower respiratory tract inflammationFAERS: 4US FAERS
159LymphadenitisFAERS: 4US FAERS
160NasopharyngitisFAERS: 4OFFSIDES
US FAERS
161Nephrotic SyndromeFAERS: 41977483CTD
OFFSIDES
SIDER
US FAERS
162Oral candidiasisFAERS: 4US FAERS
163PericarditisFAERS: 4
Canada Vigilance: 1
8101983
9167028
17440739
CTD
SIDER
Canada Vigilance
US FAERS
164PleurisyFAERS: 4OFFSIDES
SIDER
US FAERS
165PleuropericarditisFAERS: 4US FAERS
166Product taste abnormalFAERS: 4US FAERS
167ProteinuriaFAERS: 47551669CTD
SIDER
US FAERS
168Pulmonary EosinophiliaFAERS: 4US FAERS
169Sinus TachycardiaFAERS: 4US FAERS
170Skin irritationFAERS: 4US FAERS
171StressFAERS: 4OFFSIDES
US FAERS
172ThrombosisFAERS: 4US FAERS
173TremorFAERS: 4US FAERS
174VasculitisFAERS: 4SIDER
US FAERS
175WheezingFAERS: 4US FAERS
176Wrong technique in product usage processFAERS: 4US FAERS
177AbasiaFAERS: 3US FAERS
178AgitationFAERS: 3US FAERS
179AlveolitisFAERS: 3US FAERS
180Amyotrophic Lateral SclerosisFAERS: 3US FAERS
181Ankylosing spondylitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
182AnorexiaFAERS: 3SIDER
US FAERS
183Antiphospholipid SyndromeFAERS: 3US FAERS
184Autoimmune neutropeniaFAERS: 3US FAERS
185Blood creatine phosphokinase MB increasedFAERS: 3US FAERS
186Blood creatinine increasedFAERS: 3US FAERS
187Bone painFAERS: 3US FAERS
188BronchiectasisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
189Burning sensationFAERS: 3US FAERS
190CellulitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
191CryingFAERS: 3US FAERS
192Disease ProgressionFAERS: 3US FAERS
193Drug dose omissionFAERS: 3US FAERS
194Drug exposure via breast milkFAERS: 3US FAERS
195Dry skinFAERS: 3US FAERS
196False positive investigation resultFAERS: 3US FAERS
197Full blood count decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
198Gastrointestinal PainFAERS: 3SIDER
US FAERS
199GingivitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
200Granulocyte count decreasedFAERS: 3US FAERS
201Hepatitis BFAERS: 3US FAERS
202HyperpyrexiaFAERS: 3US FAERS
203HypophagiaFAERS: 3US FAERS
204IleusFAERS: 3US FAERS
205Incorrect dose administeredFAERS: 3OFFSIDES
US FAERS
206InfluenzaFAERS: 3US FAERS
207Intestinal PerforationFAERS: 3US FAERS
208Lung AbscessFAERS: 3US FAERS
209Lymph node palpableFAERS: 3US FAERS
210Lymphocyte stimulation test positiveFAERS: 3US FAERS
211Maternal exposure timing unspecifiedFAERS: 3US FAERS
212Metabolic acidosisFAERS: 3US FAERS
213NephrolithiasisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
214Neutropenic sepsisFAERS: 3OFFSIDES
US FAERS
215No adverse eventFAERS: 3US FAERS
216NoduleFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Oral painFAERS: 3US FAERS
218OsteomyelitisFAERS: 3US FAERS
219Placental InsufficiencyFAERS: 3OFFSIDES
US FAERS
220PneumothoraxFAERS: 3OFFSIDES
US FAERS
221Poor quality drug administeredFAERS: 3US FAERS
222Posterior reversible encephalopathy syndromeFAERS: 3US FAERS
223PsoriasisFAERS: 312587019CTD
OFFSIDES
US FAERS
224Pulmonary toxicityFAERS: 3US FAERS
225Reaction to drug excipientsFAERS: 3US FAERS
226RestlessnessFAERS: 3US FAERS
227RetchingFAERS: 3US FAERS
228Rheumatoid factor increasedFAERS: 3US FAERS
229Septic ShockFAERS: 3OFFSIDES
US FAERS
230SinusitisFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
231Status EpilepticusFAERS: 319050416CTD
US FAERS
232StillbirthFAERS: 3US FAERS
233TrismusFAERS: 3US FAERS
234Ultrasound liver abnormalFAERS: 3US FAERS
235Vaginal DischargeFAERS: 3US FAERS
236Visual ImpairmentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
237VitiligoFAERS: 3US FAERS
238Abscess sweat glandFAERS: 2US FAERS
239Activities of daily living impairedFAERS: 2US FAERS
240Acute psychosisFAERS: 2US FAERS
241Amylase increasedFAERS: 2US FAERS
242Anaphylactic shockFAERS: 2SIDER
US FAERS
243AnuriaFAERS: 2SIDER
US FAERS
244ApathyFAERS: 2OFFSIDES
US FAERS
245AphasiaFAERS: 27913503CTD
US FAERS
246Atrioventricular Septal DefectFAERS: 2US FAERS
247Autoimmune hepatitisFAERS: 2US FAERS
248BedriddenFAERS: 2US FAERS
249Blood glucose decreasedFAERS: 2US FAERS
250Blood urine presentFAERS: 2US FAERS
251Bone marrow toxicityFAERS: 2US FAERS
252BradykinesiaFAERS: 2US FAERS
253Central nervous system lesionFAERS: 2US FAERS
254CholestasisFAERS: 211570976
16283166
CTD
SIDER
US FAERS
255Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
256Clostridium difficile colitisFAERS: 2US FAERS
257Congenital diaphragmatic herniaFAERS: 2US FAERS
258ConstipationFAERS: 2US FAERS
259DeafnessFAERS: 2SIDER
US FAERS
260Device occlusionFAERS: 2US FAERS
261DiscomfortFAERS: 2US FAERS
262Drug dispensing errorFAERS: 2US FAERS
263DysphoniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
264DysplasiaFAERS: 2US FAERS
265Economic problemFAERS: 2US FAERS
266Electrocardiogram ST-T changeFAERS: 2US FAERS
267EnterocolitisFAERS: 2US FAERS
268Eosinophilic colitisFAERS: 2US FAERS
269Erectile dysfunctionFAERS: 2US FAERS
270Eye irritationFAERS: 2US FAERS
271Feeling ColdFAERS: 2OFFSIDES
US FAERS
272Feeling jitteryFAERS: 2US FAERS
273Foreign body sensation in eyesFAERS: 2US FAERS
274Gamma-Glutamyltransferase IncreasedFAERS: 2OFFSIDES
US FAERS
275GastritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
276GastroenteritisFAERS: 2US FAERS
277Gingival HypertrophyFAERS: 2US FAERS
278GranulomaFAERS: 26113258
11570976
CTD
OFFSIDES
US FAERS
279Hepatic necrosisFAERS: 2SIDER
US FAERS
280HyperacusisFAERS: 2US FAERS
281Idiopathic Pulmonary FibrosisFAERS: 2SIDER
US FAERS
282Intentional product use issueFAERS: 2US FAERS
283Intestinal ObstructionFAERS: 2US FAERS
284Irritable Bowel SyndromeFAERS: 2US FAERS
285Joint stiffnessFAERS: 2US FAERS
286Lupus-like syndromeFAERS: 2US FAERS
287Medication ErrorFAERS: 2US FAERS
288Medication residueFAERS: 2US FAERS
289Mental status changesFAERS: 2US FAERS
290MonoparesisFAERS: 2US FAERS
291MonoplegiaFAERS: 2US FAERS
292MyelitisFAERS: 2OFFSIDES
US FAERS
293NervousnessFAERS: 2US FAERS
294Neutrophil count decreasedFAERS: 2US FAERS
295OligohydramniosFAERS: 2US FAERS
296Oropharyngeal blisteringFAERS: 2US FAERS
297ParaparesisFAERS: 2US FAERS
298PhotophobiaFAERS: 2
Canada Vigilance: 1
19217336CTD
Canada Vigilance
US FAERS
299PneumonitisFAERS: 2US FAERS
300PolydipsiaFAERS: 2US FAERS
301PregnancyFAERS: 2US FAERS
302Productive CoughFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Pulmonary EmbolismFAERS: 2US FAERS
304Pulmonary granulomaFAERS: 2US FAERS
305Pure white cell aplasiaFAERS: 2US FAERS
306PyelonephritisFAERS: 2OFFSIDES
US FAERS
307Pyoderma GangrenosumFAERS: 2OFFSIDES
US FAERS
308RalesFAERS: 2US FAERS
309Renal cystFAERS: 2US FAERS
310Respiratory DepressionFAERS: 2US FAERS
311Schizoaffective DisorderFAERS: 2US FAERS
312SclerodermaFAERS: 2US FAERS
313Secretion dischargeFAERS: 2US FAERS
314Serum SicknessFAERS: 2SIDER
US FAERS
315ShockFAERS: 2US FAERS
316Sjogren's SyndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
317Skin UlcerFAERS: 2US FAERS
318Skin necrosisFAERS: 2US FAERS
319SyncopeFAERS: 2US FAERS
320Systemic Inflammatory Response SyndromeFAERS: 2US FAERS
321Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
322Troponin increasedFAERS: 2US FAERS
323Unevaluable eventFAERS: 2US FAERS
324UreterolithiasisFAERS: 2US FAERS
325Ventricular hypertrophyFAERS: 2US FAERS
326VertigoFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
327Vitreous floatersFAERS: 2US FAERS
328AbscessFAERS: 1US FAERS
329Accidental exposureFAERS: 1OFFSIDES
US FAERS
330AcneFAERS: 1US FAERS
331Adverse eventFAERS: 1US FAERS
332AgnosiaFAERS: 1US FAERS
333Alcohol abuseFAERS: 1US FAERS
334Alopecia AreataFAERS: 1US FAERS
335Alopecia universalisFAERS: 1US FAERS
336AmnesiaFAERS: 1US FAERS
337Amnestic DisorderFAERS: 1US FAERS
338Anal UlcerFAERS: 1US FAERS
339Angina PectorisFAERS: 1US FAERS
340Ankle FractureFAERS: 1OFFSIDES
US FAERS
341AphagiaFAERS: 1US FAERS
342AphoniaFAERS: 1OFFSIDES
US FAERS
343Apparent deathFAERS: 1US FAERS
344Arcus lipoidesFAERS: 1US FAERS
345ArteritisFAERS: 1US FAERS
346AsthenopiaFAERS: 1OFFSIDES
US FAERS
347AtaxiaFAERS: 1OFFSIDES
SIDER
US FAERS
348Bacterial sepsisFAERS: 1US FAERS
349BicytopeniaFAERS: 1US FAERS
350Bilirubin conjugated increasedFAERS: 1US FAERS
351Blood count abnormalFAERS: 1OFFSIDES
US FAERS
352Blood fibrinogen increasedFAERS: 1US FAERS
353Blood glucose increasedFAERS: 1US FAERS
354Blood pH increasedFAERS: 1US FAERS
355Blood parathyroid hormone increasedFAERS: 1US FAERS
356Blood sodium decreasedFAERS: 1US FAERS
357Blood thyroid stimulating hormone abnormalFAERS: 1US FAERS
358Blood urea increasedFAERS: 1OFFSIDES
US FAERS
359Bone erosionFAERS: 1US FAERS
360Bone marrow depressionFAERS: 1SIDER
US FAERS
361Bone marrow granulomaFAERS: 1US FAERS
362Brain natriuretic peptide increasedFAERS: 1US FAERS
363BronchitisFAERS: 1US FAERS
364BursitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
365Calcium deficiencyFAERS: 1US FAERS
366Candida sepsisFAERS: 1US FAERS
367Carpal Tunnel SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
368Cerebral atrophyFAERS: 1US FAERS
369CheilitisFAERS: 1US FAERS
370ChemotherapyFAERS: 1US FAERS
371Choanal AtresiaFAERS: 1US FAERS
372CholangiolitisFAERS: 1US FAERS
373CholangitisFAERS: 116514397CTD
US FAERS
374CholecystitisFAERS: 1US FAERS
375ChoreaFAERS: 11674893CTD
US FAERS
376Chronic granulomatous diseaseFAERS: 1US FAERS
377ColectomyFAERS: 1US FAERS
378Completed SuicideFAERS: 1US FAERS
379ConjunctivitisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
380Coombs test positiveFAERS: 1US FAERS
381Corneal defectFAERS: 1US FAERS
382Corneal epithelium defectFAERS: 1US FAERS
383Creatine phosphokinase decreasedFAERS: 1US FAERS
384Creatinine renal clearance increasedFAERS: 1US FAERS
385CystitisFAERS: 1US FAERS
386Cytomegalovirus antigen positiveFAERS: 1US FAERS
387Dacryostenosis acquiredFAERS: 1US FAERS
388Decreased immune responsivenessFAERS: 1US FAERS
389Depressed Level of ConsciousnessFAERS: 1OFFSIDES
US FAERS
390DisorientationFAERS: 1US FAERS
391Documented hypersensitivity to administered productFAERS: 1US FAERS
392Drug administration errorFAERS: 1US FAERS
393Drug screen positiveFAERS: 1US FAERS
394Drug toxicityFAERS: 1US FAERS
395Drug-disease interactionFAERS: 1US FAERS
396Duodenal UlcerFAERS: 1US FAERS
397DysgraphiaFAERS: 1US FAERS
398DysphasiaFAERS: 1US FAERS
399DysuriaFAERS: 1US FAERS
400Ear congestionFAERS: 1US FAERS
401Educational problemFAERS: 1US FAERS
402Electrocardiogram abnormalFAERS: 1US FAERS
403Electroencephalogram abnormalFAERS: 1US FAERS
404Electrolyte imbalanceFAERS: 1US FAERS
405Emotional disorderFAERS: 1US FAERS
406EncephalitisFAERS: 1US FAERS
407EnteritisFAERS: 111570976CTD
US FAERS
408Eosinophil percentage increasedFAERS: 1US FAERS
409Epidermal necrosisFAERS: 1US FAERS
410EpididymitisFAERS: 1US FAERS
411Epigastric discomfortFAERS: 1US FAERS
412EpilepsyFAERS: 1US FAERS
413EpistaxisFAERS: 1US FAERS
414Exposure via partnerFAERS: 1US FAERS
415Exposure via skin contactFAERS: 1US FAERS
416Eye InfectionFAERS: 1US FAERS
417Eye RednessFAERS: 1US FAERS
418Eye inflammationFAERS: 1US FAERS
419Facial PainFAERS: 1US FAERS
420Facial ParesisFAERS: 1US FAERS
421FasciitisFAERS: 1US FAERS
422FibromyalgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
423Fixed drug eruptionFAERS: 1US FAERS
424Food aversionFAERS: 1US FAERS
425FractureFAERS: 1US FAERS
426Gas GangreneFAERS: 1US FAERS
427GastrectomyFAERS: 1US FAERS
428Gastrointestinal perforationFAERS: 1US FAERS
429General physical health deteriorationFAERS: 1OFFSIDES
US FAERS
430GlaucomaFAERS: 1US FAERS
431GlossitisFAERS: 1US FAERS
432Grip strength decreasedFAERS: 1US FAERS
433Guillain-Barre SyndromeFAERS: 1SIDER
US FAERS
434HaematinuriaFAERS: 1US FAERS
435Hallucinations, mixedFAERS: 1US FAERS
436Haptoglobin DecreasedFAERS: 1US FAERS
437Head discomfortFAERS: 1US FAERS
438HemiparesisFAERS: 1US FAERS
439Hepatic EncephalopathyFAERS: 110394456
16283166
CTD
US FAERS
440Hilar lymphadenopathyFAERS: 1US FAERS
441Hyaluronic acid increasedFAERS: 1US FAERS
442HydrocephalusFAERS: 1US FAERS
443HypersomniaFAERS: 1US FAERS
444HypertransaminasaemiaFAERS: 1US FAERS
445Hypertrophic CardiomyopathyFAERS: 1US FAERS
446HyperventilationFAERS: 1OFFSIDES
US FAERS
447HypomaniaFAERS: 1US FAERS
448HypometabolismFAERS: 1US FAERS
449Hypothermia neonatalFAERS: 1US FAERS
450HypothyroidismFAERS: 1
Canada Vigilance: 1
12587019CTD
Canada Vigilance
US FAERS
451Idiosyncratic drug reactionFAERS: 1US FAERS
452ImmobileFAERS: 1OFFSIDES
US FAERS
453Inappropriate affectFAERS: 1US FAERS
454Inappropriate schedule of drug administrationFAERS: 1US FAERS
455IncontinenceFAERS: 1US FAERS
456Incorrect route of drug administrationFAERS: 1US FAERS
457Increased upper airway secretionFAERS: 1US FAERS
458InfertilityFAERS: 1SIDER
US FAERS
459Inflammatory marker increasedFAERS: 1US FAERS
460Infrequent bowel movementsFAERS: 1US FAERS
461Intentional product misuseFAERS: 1US FAERS
462Iron deficiencyFAERS: 1US FAERS
463Joint InstabilityFAERS: 1US FAERS
464Joint injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
465Joint warmthFAERS: 1US FAERS
466KeratopathyFAERS: 1US FAERS
467LabyrinthitisFAERS: 1US FAERS
468Large intestine perforationFAERS: 1US FAERS
469Left Ventricular HypertrophyFAERS: 1US FAERS
470Lichen PlanusFAERS: 1SIDER
US FAERS
471Liver transplant rejectionFAERS: 1US FAERS
472Lymphocyte count decreasedFAERS: 1OFFSIDES
US FAERS
473Lymphocyte percentage increasedFAERS: 1US FAERS
474LymphomaFAERS: 1OFFSIDES
US FAERS
475LymphopeniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
476MacrocytosisFAERS: 1US FAERS
477Macular degenerationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
478MalabsorptionFAERS: 1OFFSIDES
US FAERS
479Male Orgasmic DisorderFAERS: 1US FAERS
480Malignant lymphoid neoplasmFAERS: 1US FAERS
481Matrix metalloproteinase-3 increasedFAERS: 1US FAERS
482Measles antibody positiveFAERS: 1US FAERS
483MeaslesFAERS: 1US FAERS
484MegacolonFAERS: 1US FAERS
485Memory impairmentFAERS: 1US FAERS
486MeningitisFAERS: 11681789CTD
SIDER
US FAERS
487Micturition frequency decreasedFAERS: 1US FAERS
488Mixed liver injuryFAERS: 1US FAERS
489Mood swingsFAERS: 1US FAERS
490Mouth swellingFAERS: 1US FAERS
491Mucosal exfoliationFAERS: 1US FAERS
492Multiple SclerosisFAERS: 1US FAERS
493Muscle FatigueFAERS: 1US FAERS
494Muscle necrosisFAERS: 1US FAERS
495Muscle tightnessFAERS: 1US FAERS
496Muscular DystrophyFAERS: 1US FAERS
497Musculoskeletal PainFAERS: 1US FAERS
498Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
499Myotonic DystrophyFAERS: 1US FAERS
500Nasal discomfortFAERS: 1US FAERS
501Necrotising myositisFAERS: 1US FAERS
502Negative thoughtsFAERS: 1US FAERS
503NephritisFAERS: 111672959CTD
SIDER
US FAERS
504Nerve injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
505Nipah Virus InfectionFAERS: 1US FAERS
506No adverse reactionFAERS: 1US FAERS
507NocturiaFAERS: 1US FAERS
508Obsessive-Compulsive DisorderFAERS: 1US FAERS
509Occupational exposure to productFAERS: 1US FAERS
510Oculogyric crisisFAERS: 1US FAERS
511OnychoclasisFAERS: 1US FAERS
512Optic NeuropathyFAERS: 1US FAERS
513Oral fungal infectionFAERS: 1US FAERS
514OsteopeniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
515OsteoporosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
516PallorFAERS: 1SIDER
US FAERS
517Pancreatic enlargementFAERS: 1US FAERS
518Periorbital disorderFAERS: 1US FAERS
519PertussisFAERS: 1US FAERS
520Pneumatosis intestinalisFAERS: 1US FAERS
521PolyarthritisFAERS: 1US FAERS
522PolyuriaFAERS: 1SIDER
US FAERS
523Poor peripheral circulationFAERS: 1US FAERS
524Poor quality product administeredFAERS: 1US FAERS
525Post inflammatory pigmentation changeFAERS: 1US FAERS
526Post procedural complicationFAERS: 1US FAERS
527Postoperative feverFAERS: 1US FAERS
528Pre-EclampsiaFAERS: 1US FAERS
529Pre-existing condition improvedFAERS: 1US FAERS
530Product container seal issueFAERS: 1US FAERS
531Product physical issueFAERS: 1US FAERS
532Product residue presentFAERS: 1US FAERS
533Product shape issueFAERS: 1US FAERS
534Product size issueFAERS: 1US FAERS
535Product use complaintFAERS: 1US FAERS
536Protein total decreasedFAERS: 1US FAERS
537PseudolymphomaFAERS: 1US FAERS
538Psychiatric symptomFAERS: 1US FAERS
539Rectal tenesmusFAERS: 1US FAERS
540Renal painFAERS: 1US FAERS
541Renal tubular disorderFAERS: 1US FAERS
542Renal tubular necrosisFAERS: 1OFFSIDES
US FAERS
543Renal vasculitisFAERS: 1US FAERS
544Restrictive pulmonary diseaseFAERS: 1US FAERS
545SarcoidosisFAERS: 1US FAERS
546ScleritisFAERS: 1US FAERS
547ScleromalaciaFAERS: 1US FAERS
548Sensitivity to weather changeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
549Seronegative arthritisFAERS: 1US FAERS
550Sexual DysfunctionFAERS: 1US FAERS
551Skin PapillomaFAERS: 1US FAERS
552SneezingFAERS: 1US FAERS
553Soft tissue swellingFAERS: 1US FAERS
554SomnolenceFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
555Sperm concentration decreasedFAERS: 1US FAERS
556Spermatozoa morphology abnormalFAERS: 1US FAERS
557Spina BifidaFAERS: 1US FAERS
558Spinal fusion surgeryFAERS: 1US FAERS
559StuporFAERS: 18105680CTD
US FAERS
560Suicide attemptFAERS: 1US FAERS
561Suspected counterfeit productFAERS: 1US FAERS
562TachyarrhythmiaFAERS: 1US FAERS
563TalipesFAERS: 1US FAERS
564Temporal ArteritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
565TensionFAERS: 1US FAERS
566Therapeutic response unexpectedFAERS: 1US FAERS
567Therapy cessationFAERS: 1US FAERS
568Therapy changeFAERS: 1US FAERS
569Therapy non-responderFAERS: 1US FAERS
570ThirstFAERS: 1US FAERS
571TonsillitisFAERS: 1US FAERS
572Transaminases abnormalFAERS: 1US FAERS
573UlcerFAERS: 125727887
25729217
CTD
US FAERS
574Upper-airway cough syndromeFAERS: 1US FAERS
575Urinary IncontinenceFAERS: 1US FAERS
576Urine ketone body presentFAERS: 1US FAERS
577Venous ThrombosisFAERS: 1US FAERS
578Venous stasisFAERS: 1US FAERS
579Visual brightnessFAERS: 1US FAERS
580Vitamin B1 decreasedFAERS: 1US FAERS
581Vulvovaginal pruritusFAERS: 1US FAERS
582Wheelchair userFAERS: 1US FAERS
583White blood cell count abnormalFAERS: 1OFFSIDES
US FAERS
584Wound ComplicationFAERS: 1US FAERS
585Wrong drug administeredFAERS: 1US FAERS
586pH urine abnormalFAERS: 1US FAERS
587Abnormalities, Drug-Induced6133211CTD
588Acetonaemic vomitingOFFSIDES
589AcidosisOFFSIDES
590Acute bronchitisOFFSIDES
591AdenocarcinomaOFFSIDES
592Agammaglobulinemia25555CTD
593Albumin globulin ratio increasedOFFSIDES
594AmyloidosisOFFSIDES
595Anaphylactoid ReactionSIDER
596Anemia, Hemolytic

View details

CTD
597Anemia, Macrocytic2571387
2879599
2882808
CTD
598Anemia, Megaloblastic

View details

CTD
599Anemia2572687
6130169
CTD
600Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis10693882CTD
601Antiphospholipid antibodies positiveOFFSIDES
602Aphthous StomatitisOFFSIDES
603Arthritis, Psoriatic17408446CTD
604AscitesOFFSIDES
605Asthenozoospermia10689203
17166698
CTD
606Atherosclerosis obliteransOFFSIDES
607Autoimmune Diseases7788172
7913503
CTD
608AzoospermiaSIDER
609B-cell lymphoma stage IVOFFSIDES
610Bacterial test positiveOFFSIDES
611Band neutrophil percentage increasedOFFSIDES
612Behcet Syndrome15870978CTD
613Beta 2 microglobulin increasedOFFSIDES
614Blood 25-hydroxycholecalciferol decreasedOFFSIDES
615Blood amylase increasedOFFSIDES
616Blood and lymphatic system disordersSIDER
617Blood beta-D-glucan increasedOFFSIDES
618Blood creatinine decreasedOFFSIDES
619Blood glucose fluctuationOFFSIDES
620Blood lactate dehydrogenase decreasedOFFSIDES
621Blood potassium increasedOFFSIDES
622Bone Marrow Diseases19050416CTD
623Bone contusionCanada Vigilance: 1Canada Vigilance
624Brain Diseases6124962CTD
625BunionOFFSIDES
626C-reactive protein abnormalOFFSIDES
627Calculi8102080CTD
628Carcinoma, Transitional Cell12587019CTD
629Cardiac Tamponade2563191
2894766
CTD
630Cauda Equina SyndromeSIDER
631Cell DeathOFFSIDES
632Chemical and Drug Induced Liver Injury

View details

CTD
633Cholangitis, Sclerosing17116962CTD
634Citrobacter infectionOFFSIDES
635Colon adenomaOFFSIDES
636Colonic Neoplasms1358165CTD
637Corneal abscessOFFSIDES
638Crohn Disease

View details

CTD
639CrystalluriaSIDER
640CyanosisCanada Vigilance: 119187CTD
OFFSIDES
SIDER
Canada Vigilance
641Cytomegalovirus antibody positiveOFFSIDES
642Diarrhea7944624
9805178
30408459
CTD
OFFSIDES
643Diffuse Large B-Cell LymphomaOFFSIDES
644DistressSIDER
645DiuresisSIDER
646DrowsinessSIDER
647Drug Eruptions

View details

CTD
648Drug delivery system malfunctionOFFSIDES
649Drug level below therapeuticOFFSIDES
650DysmorphismOFFSIDES
651Ear and labyrinth disordersSIDER
652Edema

View details

CTD
653Electrocardiogram ST segment abnormalOFFSIDES
654Emotional distressSIDER
655EndophthalmitisOFFSIDES
656Endotoxemia29731490CTD
657Epstein-Barr virus antibody positiveOFFSIDES
658ErysipelasOFFSIDES
659Exanthema

View details

CTD
660Factor II deficiencySIDER
661Fever

View details

CTD
662Gastrointestinal Diseases1972633CTD
663Gastrointestinal motility disorderOFFSIDES
664Glioblastoma15328202CTD
665Hamman-Rich syndromeSIDER
666Heinz bodiesCanada Vigilance: 1Canada Vigilance
667Hemorrhage25727887
25729217
CTD
668Hepatic congestionOFFSIDES
669HoarsenessOFFSIDES
670Hyperemia22427801
25727887
CTD
671Hyperplasia12587019
19234301
CTD
672HyperreflexiaOFFSIDES
673Hypertensive emergencyOFFSIDES
674Idiopathic intracranial hypertension with papilledema18070060CTD
675Ileal StenosisOFFSIDES
676ImmunosuppressionOFFSIDES
677Impaired quality of lifeCanada Vigilance: 1Canada Vigilance
678Increased skin sensitivitySIDER
679InfestationSIDER
680Inflammatory Bowel Diseases

View details

CTD
681Injection site irritationOFFSIDES
682Injury asphyxiationOFFSIDES
683Intervertebral disc compressionOFFSIDES
684Jaundice, Obstructive2880997CTD
685Kidney Calculi7910643CTD
686Kidney Diseases9374926
15188168
CTD
687Kidney Failure, Chronic1353741CTD
688Kidney FailureOFFSIDES
689LaryngitisCanada Vigilance: 1Canada Vigilance
690Latent TuberculosisCanada Vigilance: 1Canada Vigilance
691Leukemia, Large Granular Lymphocytic12587019CTD
692Liver Cirrhosis, Experimental15633128CTD
693Liver Failure, Acute

View details

CTD
694Liver Failure13680174CTD
695Loss of personal independence in daily activitiesCanada Vigilance: 3Canada Vigilance
696Lung diseases20084578CTD
697Lung infection pseudomonalOFFSIDES
698Lupus Erythematosus, Systemic2894766
6124962
9374926
CTD
699Lupus ErythematosusSIDER
700Lymphatic Abnormalities12587019CTD
701Lymphatic Diseases11672959
17032600
18084702
CTD
702Lymphocyte count abnormalOFFSIDES
703MYELODYSPLASTIC SYNDROMESIDER
704MalnutritionSIDER
705Massive Hepatic Necrosis1348259
16283166
CTD
706MetatarsalgiaOFFSIDES
707Methemoglobinemia4151648CTD
708Micronuclei, Chromosome-Defective12587019CTD
709Mixed Connective Tissue DiseaseOFFSIDES
710Monocyte percentage decreasedOFFSIDES
711Mucocutaneous Lymph Node Syndrome1992637CTD
712Necrolysis epidermalSIDER
713Necrosis12377949
22427801
CTD
714Neoplasm Metastasis19015640CTD
715Nephritis, Interstitial

View details

CTD
716NephrosisSIDER
717NeuralgiaCanada Vigilance: 1Canada Vigilance
718NeuritisSIDER
719Neurotoxicity Syndromes

View details

CTD
720Neutropenic colitisSIDER
721Neutrophil count abnormalOFFSIDES
722OligospermiaSIDER
723OliguriaSIDER
724Open woundOFFSIDES
725Panic DisorderOFFSIDES
726Papilloma12587019CTD
727Paraproteinemias12235076CTD
728Paresis6146502CTD
729Paresthesia12763355CTD
730Peripheral Nervous System Diseases1351312
2858845
CTD
731Peripheral occlusive diseaseOFFSIDES
732Pharyngeal lesionOFFSIDES
733Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
734Pituitary Diseases12587019CTD
735Pityriasis Lichenoides et Varioliformis AcutaSIDER
736Platelet count abnormalOFFSIDES
737Pneumocystis jiroveci pneumoniaOFFSIDES
738Polyarteritis NodosaSIDER
739PresbyopiaOFFSIDES
740Proctocolitis19212915CTD
OFFSIDES
741Product dose omissionCanada Vigilance: 1Canada Vigilance
742Protein total increasedOFFSIDES
743Protein urine presentSIDER
744PseudarthrosisOFFSIDES
745PseudomononucleosisSIDER
746PterygiumOFFSIDES
747Pulmonary congestionOFFSIDES
748Pustular psoriasisOFFSIDES
749Raynaud Disease6104805
6146597
CTD
750Reaction gastrointestinalSIDER
751Rectosigmoid cancerOFFSIDES
752Recurrence22119283CTD
753Renal Insufficiency19509026CTD
754Renal abscessOFFSIDES
755Reticulocytosis19187
4146729
CTD
756RhinorrheaOFFSIDES
757Seizures

View details

CTD
758Skin Diseases, Vascular8298382CTD
759Skin lacerationOFFSIDES
760Small Intestinal StenosisOFFSIDES
761Spermatic Cord Torsion16626516CTD
762Spinal Diseases2573801CTD
763Spondylarthropathies8104747
9805178
CTD
764Sputum retentionOFFSIDES
765Stomach Neoplasms12587019CTD
766SunburnCanada Vigilance: 1Canada Vigilance
767Taste DisordersSIDER
768Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
769Therapeutic product effect incompleteCanada Vigilance: 23Canada Vigilance
770Toxic pustulodermaSIDER
771Tympanic Membrane PerforationOFFSIDES
772Urolithiasis10349305
14550462
CTD
773Urologic Neoplasms12587019CTD
774Vascular System Injuries19234301CTD
775Vascular purpuraSIDER
776Vasculitis, Leukocytoclastic, Cutaneous7788172CTD
777Ventricular hypokinesiaOFFSIDES
778Viral myocarditisOFFSIDES
779Wound InfectionOFFSIDES
780anaphylaxis1972633
9597688
CTD
781pseudomembranous colitisSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.